All News

Day 4 Report from #ACR21
My favorite three presentations from day 4 at ACR 2021 included the following:
-Breakthrough Infections in Rheumatic Disease Patients
-Secukinumab in Giant Cell Arteritis
-STOP-Gout – Febuxostat is Noninferior to Allopurinol
https://t.co/zJRS5AHjc1 https://t.co/FuwCFCK14r
Links:
Dr. John Cush RheumNow ( View Tweet)

Cognitive Impairment in Patients with Rheumatoid Arthritis
Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts presented at #ACR21.
https://t.co/zz8auqZjIW https://t.co/RSHjyonBrj
Links:
Dr. John Cush RheumNow ( View Tweet)

Predictors to Flare in SpA: Dr. Antoni Chan ( @synovialjoints ) discusses abstracts #0929 and #0916 presented at the #ACR21 annual meeting.
https://t.co/C0NLSTzlW9 https://t.co/3BiW2L6BJu
Links:
Dr. John Cush RheumNow ( View Tweet)

Can we Use Frax Score in RA Patients? Dr. Eric Dein ( @ejdein1) reviews abstract #0563 presented at the #ACR21 annual meeting.
https://t.co/UcvTWhlcvW https://t.co/8AdHa2enlz
Links:
Dr. John Cush RheumNow ( View Tweet)

An Exclusive Interview with Dr. Al Kim (#Wowkim): Dr. Kathryn Dao ( @KDAO2011 ) interviews Dr. Alfred Kim (aka #Wowkim) about the exciting work he's presenting at the #ACR21 annual meeting.
https://t.co/34EZIz2OFG https://t.co/mhaUcIhTKu
Links:
Dr. John Cush RheumNow ( View Tweet)

ACR21 Best Abstracts - Day 4
On the last day of #ACR21 Annual Meeting, the RheumNow faculty selected their favorite reports. Follow the link below for our selections!
https://t.co/O6IXf5iB3d https://t.co/G1yUzqwcuk
Links:
Dr. John Cush RheumNow ( View Tweet)

Predictors of Remission and Low Disease Activity in SLE
Dr. Sheila Reyes ( @RHEUMarampa) shares results of abstracts discussed at #ACR21.
https://t.co/FayzgyGiP8 https://t.co/QvKbKnznmS
Links:
Dr. John Cush RheumNow ( View Tweet)

Serum Biomarkers Distinguish Radiographic Progression in PsA: Dr. Robert Chao ( @doctorRBC ) discusses abstract #0449 presented at the #ACR21 annual meeting. https://t.co/Q9JQyx7K1A
Dr. John Cush RheumNow ( View Tweet)

Emapalumab for the treatment of macrophage activation syndrome
Dr. Yuz Yusof ( @Yuz6Yusof) summarizes abstracts presented at #ACR21.
https://t.co/TXdbwA64wg https://t.co/VLiLIsEkxS
Links:
Dr. John Cush RheumNow ( View Tweet)

Predictors of mortality in RA lung disease? Dr. Meral El Ramahi ( @MeralElRamahiMD) discusses abstract #0290 presented at the #ACR21 annual meeting.
https://t.co/swo0eexWHl https://t.co/dVpeTQIwTb
Links:
Dr. John Cush RheumNow ( View Tweet)

Depression in Axial Spondyloarthritis: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstract #1305 presented at the #ACR21 annual meeting.
https://t.co/KUGM61fpZK https://t.co/YhyvGUJkO0
Links:
Dr. John Cush RheumNow ( View Tweet)

#ACR21 – Day 3 Report
Day 3 presentations were big! We share a few of our favorites.
https://t.co/UfWIFq2lWb https://t.co/Z8VKGXvPzz
Links:
Dr. John Cush RheumNow ( View Tweet)

Monitoring Infliximab Drug Levels Improves Efficacy
Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?
Dr. Robert Chao ( @doctorRBC) shares data presented at #ACR21.
https://t.co/IJ9by2iguK https://t.co/KBIWTs9iPV
Links:
Dr. John Cush RheumNow ( View Tweet)

Hypertension in AS: Drs. Swetha Ann Alexander ( @swethaann23) interviews Dr. Jean Liew about abstract #0910, presented Sunday at the #ACR21 annual meeting.
https://t.co/3oHnLbQAl8 https://t.co/dwxlb4GSzb
Links:
Dr. John Cush RheumNow ( View Tweet)

Pulse Pressure as a Predictor of Carotid Plaque in RA: Dr. Meral El Ramahi ( @MeralElRamahiMD ) discusses abstract #0276 presented at the #ACR21 annual meeting.
https://t.co/TkWJ2ehgma https://t.co/6OoTLKlQ1H
Links:
Dr. John Cush RheumNow ( View Tweet)

NrAxSpA progression to AxSpA: Dr. Rachel Tate ( @uptoTate) discusses non-radiographic Axial Spondyloarthritis and progression to AS, data from Abstract #0907 presented at the #ACR21 annual meeting.
https://t.co/GXJMJ5D9vG https://t.co/JWiQakf30E
Links:
Dr. John Cush RheumNow ( View Tweet)

More severe COVID-19 outcomes in African American, Hispanic individuals with SLE
A study from #ACR21 discussing data from the GRA describes the association between race/ethnicity on COVID-19 outcomes specifically in lupus patients (Abstract #1933).
https://t.co/3X7wydVCQR https://t.co/NNbaM0njTX
Links:
Dr. John Cush RheumNow ( View Tweet)

To Clot or Not to Clot with Drs. Janet Pope ( @Janetbirdope) and Jeffrey Sparks ( @jeffsparks )
#ACR21
https://t.co/vfOGgTflfl https://t.co/V9cBGAnGnN
Links:
Dr. John Cush RheumNow ( View Tweet)

Risks associated with mortality in VEXAS
Dr. Md Yuzaiful Md Yusof ( @Yuz6Yusof) shares findings from abstracts presented at #ACR21.
https://t.co/BgYrOaraXC https://t.co/KYLjpi8baP
Links:
Dr. John Cush RheumNow ( View Tweet)

Best of PsA Saturday: Dr Rachel Tate ( @uptoTate) discusses "best of" abstracts - #0488, #0453 and #0064 - presented Saturday, at the #ACR21 annual meeting.
https://t.co/nMUH6yJTmo https://t.co/x5htYZHq3v
Links:
Dr. John Cush RheumNow ( View Tweet)